The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Jan. 25, 2010
Applicants:

Stephan Schann, Graffenstaden, FR;

Stanislas Mayer, Eschau, FR;

Inventors:

Stephan Schann, Graffenstaden, FR;

Stanislas Mayer, Eschau, FR;

Assignee:

Kaldi Pharma, SAS, Illkirch Graffenstaden, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A01N 43/42 (2006.01); C07D 215/00 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract

The present invention provides new compounds with high affinity for adenosine Areceptors. It also provides antagonists of adenosine Areceptors and their use as medicaments for the treatment and/or prophylaxis of diseases and disorders where the partial or total inactivation of adenosine Areceptors signalling pathways could be beneficial such as Alzheimer's disease, Parkinson's disease, attention deficit and hyperactivity disorders (ADHD), Huntington's disease, neuroprotection, schizophrenia, anxiety and pain. The present invention further relates to pharmaceutical compositions containing such new compounds with high affinity for adenosine Areceptors and their use for the treatment and/or prophylaxis of diseases and disorders where the partial or total inactivation of adenosine Areceptors could be beneficial.


Find Patent Forward Citations

Loading…